Year |
Citation |
Score |
2007 |
Sun K, Montana V, Chellappa K, Brelivet Y, Moras D, Maeda Y, Parpura V, Paschal BM, Sladek FM. Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization. Molecular Endocrinology (Baltimore, Md.). 21: 1297-311. PMID 17389749 DOI: 10.1210/Me.2006-0300 |
0.697 |
|
2006 |
Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, Owen LB, Liu X, Sladek FM. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. The Biochemical Journal. 400: 303-13. PMID 16895524 DOI: 10.1042/Bj20060614 |
0.662 |
|
2004 |
Fukazawa T, Maeda Y, Sladek FM, Owen-Schaub LB. Development of a cancer-targeted tissue-specific promoter system. Cancer Research. 64: 363-9. PMID 14729646 DOI: 10.1158/0008-5472.Can-03-2507 |
0.546 |
|
2003 |
Li QJ, Yang SH, Maeda Y, Sladek FM, Sharrocks AD, Martins-Green M. MAP kinase phosphorylation-dependent activation of Elk-1 leads to activation of the co-activator p300. The Embo Journal. 22: 281-91. PMID 12514134 DOI: 10.1093/Emboj/Cdg028 |
0.656 |
|
2002 |
Maeda Y, Rachez C, Hawel L, Byus CV, Freedman LP, Sladek FM. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Molecular Endocrinology (Baltimore, Md.). 16: 1502-10. PMID 12089346 DOI: 10.1210/Mend.16.7.0883 |
0.674 |
|
2002 |
Maeda Y, Seidel SD, Wei G, Liu X, Sladek FM. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity. Molecular Endocrinology (Baltimore, Md.). 16: 402-10. PMID 11818510 DOI: 10.1210/Mend.16.2.0769 |
0.703 |
|
2000 |
Bogan AA, Dallas-Yang Q, Ruse MD, Maeda Y, Jiang G, Nepomuceno L, Scanlan TS, Cohen FE, Sladek FM. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha. Journal of Molecular Biology. 302: 831-51. PMID 10993727 DOI: 10.1006/Jmbi.2000.4099 |
0.688 |
|
Show low-probability matches. |